Home/ Stocks/ FBIO

Fortress Biotech, Inc.

FBIO XNAS

$2.92 +0.02 (+0.58%) ▲ 15-min delayed

Open

$3.00

High

$3.00

Low

$2.89

Volume

341.2K

Market Cap

$92.49M

About Fortress Biotech, Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 101 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$17.63M	$8.83M	$0.13
Q2 2025	$16.41M	$-11,654,000	$0.50
Q1 2025	$13.14M	$-24,691,000	$-0.48
FY 2024	$57.67M	$-120,855,000	$-2.69

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026

Calendar →

Related Market News

No specific coverage for FBIO yet. Check out our latest market news or earnings calendar.

Get FBIO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Fortress Biotech, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.